Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

[1]  R. Sherwin,et al.  Peroral gene therapy of lactose intolerance using an adeno-associated virus vector , 1998, Nature Medicine.

[2]  H. Greenberg,et al.  Protective Immunity Induced by Oral Immunization with a Rotavirus DNA Vaccine Encapsulated in Microparticles , 1998, Journal of Virology.

[3]  K. Leong,et al.  DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[4]  E. Moon,et al.  Toxicities of 166Holmium-chitosan in mice. , 1998, Arzneimittel-Forschung.

[5]  A. Bernkop‐Schnürch,et al.  Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[6]  R. Buckland,et al.  Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. , 1997, The Journal of general virology.

[7]  H. Nelson,et al.  Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. , 1997, The Journal of allergy and clinical immunology.

[8]  S. Rossi,et al.  Characterization of rheological and mucoadhesive properties of three grades of chitosan hydrochloride. , 1997, Farmaco.

[9]  D A Peterson,et al.  Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Lowe,et al.  Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. , 1997, Journal of pharmaceutical sciences.

[11]  I. Orme,et al.  Induction of immunity by DNA vaccination: application to influenza and tuberculosis. , 1997, Behring Institute Mitteilungen.

[12]  T. Maruyama,et al.  Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. , 1996, Journal of pharmaceutical sciences.

[13]  C. Hsu,et al.  Inhibition of specific IgE response in vivo by allergen-gene transfer. , 1996, International immunology.

[14]  Shau-ku Huang,et al.  Immunoprophylaxis of allergen–induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization , 1996, Nature Medicine.

[15]  E. Raz,et al.  Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Lockey,et al.  Anaphylaxis. A review of 266 cases. , 1995, Archives of internal medicine.

[17]  D. Pardoll,et al.  Exposing the immunology of naked DNA vaccines. , 1995, Immunity.

[18]  E. Raz,et al.  Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Deuchi,et al.  Increasing Effect of a Chitosan and Ascorbic Acid Mixture on Fecal Dietary Fat Excretion , 1994 .

[20]  Y. Kawashima,et al.  Mucoadhesion of polymer-coated liposomes to rat intestine in vitro. , 1994, Chemical & pharmaceutical bulletin.

[21]  J. Marshall,et al.  Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. , 1994, Journal of immunology.

[22]  D. Attwood,et al.  Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. , 1994, Biological & pharmaceutical bulletin.

[23]  M. W. Yocum,et al.  Assessment of patients who have experienced anaphylaxis: a 3-year survey. , 1994, Mayo Clinic proceedings.

[24]  T. Mitsuoka,et al.  Hypocholesterolemic Effect of Chitosan in Adult Males , 1993 .

[25]  Bin Wang,et al.  Gene inoculation generates immune responses against human immunodeficiency virus type 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Sampson,et al.  Fatal and near-fatal anaphylactic reactions to food in children and adolescents. , 1992, The New England journal of medicine.

[27]  N. Lycke,et al.  Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation. , 1990, Journal of immunology.

[28]  B. Huber,et al.  Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation , 1990, The Journal of experimental medicine.

[29]  W Q Sturner,et al.  Fatal food-induced anaphylaxis. , 1988, JAMA.